Home   Site Map   About Roche   Contact Us   Help   
nullnull
Clinical. Credible. Convenient.
Not a Member? Log In Forgot Password? Instant Access Code
Sign Up
»
E-mail: Password: Code:
  Remember Me Log In
»
Go
»
Main Menu
Meeting Calendar

Select a link below to view details.
Previous March 2010 Next
S M T W T F S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
Rheumatoid Arthritis Clinical Trials

Rheumatoid Arthritis Clinical Trials Database
Real-time, comprehensive global Rheumatoid Arthritis clinical trials database

  • Global clinical development on a trial-by-trial basis
  • Search by any drug name
  • Search by any status and/or phase of the trial
TrialTrove™Locked Content Click
Here
 
  What is this?
 
   
 
Roche Clinical Trials
 
Recruiting Comparative double blind placebo controlled clinical study on tocilizumab rapid efficacy on patients relief in rheumatoïd arthritis with an inadequate response to DMARDs or anti TNF :TORPEDO
 
 
Recruiting An open label study to evaluate the safety and effect on disease activity of tocilizumab in patients with active rheumatoid arthritis on background non-biologic DMARDs who have an inadequate response to current non-biologic DMARDs.
 
 
Recruiting An Extension Phase of the Multi-National Open-Label Study (MA21573) to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy.
 
 
Recruiting A randomized, active controlled, double-blind, study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera®)and tocilizumab (RoActemra®) versus tocilizumab in patients with active rheumatoid arthritis with an incomplete response to methotrexate
 
 
Recruiting Open label, multicenter study to evaluate the effect of tocilizumab in combination with DMARDs in the inhibition of progression of synovitis, bone marrow edema, and erosions evaluated by magnetic resonance imaging (MRI) of the hand of patients with rheumatoid arthritis
 
 
Recruiting A single-arm, open-label study of the safety and reduction of signs and symptoms during treatment with tocilizumab in combination with methotrexate, in patients with moderate to severe active rheumatoid arthritis
 
 
Recruiting A single arm, open-label study of early improvement of anemia and fatigue during treatment with tocilizumab (TCZ) in combination with DMARDs, in adult patients with moderate to severe active rheumatoid arthritis.
 
 
Recruiting Open-label, multicenter, randomized, parallel study to investigate pk, pd, efficacy and safety of tocilizumab (TCZ, RO4877533) following subcutaneous administration of TCZ 162 mg weekly or every other week in combination with methotrexate in patients with rheumatoid arthritis
 
 
Recruiting Local open-label multicenter study to evaluate the quality of life in patients with moderate to severe active rheumatoid arthritis and an inadequate response to DMARDs when adding tocilizumab (TCZ)
 
 
Recruiting Randomized placebo-controlled study of two treatment strategies based on tocilizumab (TCZ) with or without methotrexate (MTX) and possible addition of other disease-modifying anti-rheumatic drugs (DMARDs) in patients...
 
Clinical Trials Registry and Results
Visit Roche Trials for more information on completed Roche clinical studies.

ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers.

RocheInvestigators.com: Investigators interested in applying to participate in the U.S. arm of global development clinical trials sponsored by Hoffmann-La Roche Inc., please click the link.